quant Healthcare Fund Direct Growth
EquitySector - HealthcareVery High Risk
Direct
NAV (19-Nov-24)
Returns (Since Inception)
Fund Overview
Fund Size
₹437 Cr
Expense Ratio
0.69%
ISIN
INF966L01CD0
Minimum SIP
₹1,000
Exit Load
1.00%
Inception Date
18 Jul 2023
About this fund
As of 19-Nov-24, it has a Net Asset Value (NAV) of ₹16.10, Assets Under Management (AUM) of 437.41 Crores, and an expense ratio of 0.69%.
- quant Healthcare Fund Direct Growth has given a CAGR return of 42.57% since inception.
- The fund's asset allocation comprises around 98.79% in equities, 0.00% in debts, and 1.21% in cash & cash equivalents.
- You can start investing in quant Healthcare Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.
Performance against Category Average
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+44.79%
+41.83% (Cat Avg.)
Since Inception
+42.57%
— (Cat Avg.)
Portfolio Summaryas of 31st October 2024
| Equity | ₹432.13 Cr | 98.79% |
| Others | ₹5.29 Cr | 1.21% |
Top Holdings
All Holdings
Equity
Debt & Others
| Name | Type  | Amount | Holdings |
|---|---|---|---|
| RPG Life Sciences Ltd | Equity | ₹38.39 Cr | 8.78% |
| Aster DM Healthcare Ltd Ordinary Shares | Equity | ₹31.35 Cr | 7.17% |
| Reliance Industries Ltd | Equity | ₹30.53 Cr | 6.98% |
| Aurobindo Pharma Ltd | Equity | ₹30.35 Cr | 6.94% |
| Pfizer Ltd | Equity | ₹29.23 Cr | 6.68% |
| HFCL Ltd | Equity | ₹29.08 Cr | 6.65% |
| GlaxoSmithKline Pharmaceuticals Ltd | Equity | ₹27.39 Cr | 6.26% |
| Ipca Laboratories Ltd | Equity | ₹27.17 Cr | 6.21% |
| Glenmark Life Sciences Ltd | Equity | ₹26.04 Cr | 5.95% |
| Zydus Wellness Ltd | Equity | ₹25.01 Cr | 5.72% |
| Sequent Scientific Ltd | Equity | ₹24.55 Cr | 5.61% |
| Zydus Lifesciences Ltd | Equity | ₹19.52 Cr | 4.46% |
| SMS Pharmaceuticals Ltd | Equity | ₹19.49 Cr | 4.46% |
| Aarti Pharmalabs Ltd | Equity | ₹17.96 Cr | 4.11% |
| Future on Divi's Laboratories Ltd | Equity - Future | ₹13.05 Cr | 2.98% |
| Torrent Pharmaceuticals Ltd | Equity | ₹10.99 Cr | 2.51% |
| Suven Life Sciences Ltd | Equity | ₹10.43 Cr | 2.38% |
| Treps 04-Nov-2024 Depo 10 | Cash - Repurchase Agreement | ₹8.69 Cr | 1.99% |
| Divi's Laboratories Ltd | Equity | ₹5.8 Cr | 1.33% |
| Alembic Pharmaceuticals Ltd | Equity | ₹5.62 Cr | 1.29% |
| Sanofi Consumer Healthcare India Ltd | Equity | ₹3.89 Cr | 0.89% |
| Thyrocare Technologies Ltd | Equity | ₹3.82 Cr | 0.87% |
| Nca-Net Current Assets | Cash | ₹-3.4 Cr | 0.78% |
| Ami Organics Ltd | Equity | ₹2.47 Cr | 0.57% |
Allocation By Market Cap (Equity)
Large Cap Stocks
18.26%
Mid Cap Stocks
19.41%
Small Cap Stocks
60.23%
Allocation By Credit Quality (Debt)
AAA
Other Allocation
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Healthcare | ₹331.99 Cr | 75.90% |
| Energy | ₹30.53 Cr | 6.98% |
| Technology | ₹29.08 Cr | 6.65% |
| Consumer Defensive | ₹25.01 Cr | 5.72% |
| Basic Materials | ₹2.47 Cr | 0.57% |
Risk & Performance Ratios
Standard Deviation
This fund
--
Cat. avg.
15.67%
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
0.91
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
1.69
Higher the better
Fund Managers
Sanjeev Sharma
Since July 2023
Vasav Sahgal
Since July 2023
Ankit A. Pande
Since July 2023
Sandeep Tandon
Since July 2023
Additional Scheme Detailsas of 31st October 2024
ISIN INF966L01CD0 | Expense Ratio 0.69% | Exit Load 1.00% | Fund Size ₹437 Cr | Age 1 year 4 months | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark Nifty Healthcare TR INR |
Investment Objective
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Tax Treatment
Capital Gains Taxation:
Dividend Taxation:
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Similar Sector - Healthcare Funds
| Fund name | Expense Ratio | Exit Load | Fund size | 1Y  |
|---|---|---|---|---|
| Motilal Oswal S&P BSE Healthcare ETF Very High Risk | 0.2% | - | ₹28.64 Cr | 44.1% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Very High Risk | 0.9% | 1.0% | ₹881.52 Cr | 37.7% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth Very High Risk | 2.3% | 1.0% | ₹881.52 Cr | 35.9% |
| Aditya Birla Sun Life Nifty Healthcare ETF Very High Risk | 0.2% | - | ₹40.84 Cr | 39.2% |
| ITI Pharma and Healthcare Fund Direct Growth Very High Risk | 0.5% | 1.0% | ₹208.21 Cr | 46.9% |
| ITI Pharma and Healthcare Fund Regular Growth Very High Risk | 2.4% | 1.0% | ₹208.21 Cr | 44.1% |
| Mirae Asset Healthcare Fund Direct Growth Very High Risk | 0.5% | 1.0% | ₹2770.21 Cr | 39.5% |
| Mirae Asset Healthcare Fund Regular Growth Very High Risk | 1.9% | 1.0% | ₹2770.21 Cr | 37.5% |
| Nippon India Nifty Pharma ETF Very High Risk | 0.2% | - | ₹852.28 Cr | 38.3% |
| Axis NIFTY Healthcare ETF Very High Risk | 0.3% | - | ₹19.81 Cr | 38.2% |
About the AMC
Quant Mutual Fund
Total AUM
₹1,02,961 Cr
Address
A.M. Road, Prabhadevi, Mumbai, 400025
Other Funds by Quant Mutual Fund
| Fund name | Expense Ratio | Exit Load | Fund size | 1Y |
|---|---|---|---|---|
| Quant Commodities Fund Direct Growth Very High Risk | 0.9% | 1.0% | ₹492.72 Cr | - |
| Quant Momentum Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹2116.61 Cr | - |
| Quantum Small Cap Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹91.22 Cr | 20.5% |
| Quant Teck Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹424.38 Cr | 33.3% |
| 360 ONE Quant Fund Direct Growth Very High Risk | 0.4% | 1.0% | ₹561.77 Cr | 35.6% |
| Quant Value Fund Direct Growth Very High Risk | 0.5% | 1.0% | ₹1959.26 Cr | 43.7% |
| Nippon India Quant Fund Direct Growth Very High Risk | 0.4% | 0.0% | ₹83.17 Cr | 32.5% |
| Quant BFSI Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹629.72 Cr | 25.9% |
| quant Healthcare Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹437.41 Cr | 44.8% |
| DSP Quant Fund Direct Growth Very High Risk | 0.6% | 0.0% | ₹1069.84 Cr | 19.2% |
| ICICI Prudential Quant Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹95.85 Cr | 27.5% |
| Axis Quant Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹1091.75 Cr | 23.2% |
| Quant Quantamental Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹2428.23 Cr | 29.3% |
| Tata Quant Fund Direct Growth Very High Risk | 0.9% | 1.0% | ₹67.78 Cr | 21.1% |
| Quant Focused fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹1120.71 Cr | 28.5% |
| Quant Large and Mid Cap Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹3708.99 Cr | 31.7% |
| Quant Active Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹10530.63 Cr | 23.5% |
| Quant Small Cap Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹26330.82 Cr | 37.7% |
| Quant Absolute Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹2250.71 Cr | 24.3% |
| Quant Infrastructure Fund Direct Growth Very High Risk | 0.7% | 0.0% | ₹3599.01 Cr | 37.5% |
| Quant Multi Asset Fund Direct Growth High Risk | 0.6% | 1.0% | ₹3025.56 Cr | 37.9% |
| Quant Flexi Cap Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹7513.82 Cr | 32.6% |
| Quant Tax Plan Direct Growth Very High Risk | 0.7% | 0.0% | ₹10979.71 Cr | 26.6% |
| Quant Liquid Plan Direct Growth Moderate Risk | 0.3% | 0.0% | ₹2034.48 Cr | 7.3% |
| Quant Mid Cap Fund Direct Growth Very High Risk | 0.6% | 0.0% | ₹8940.54 Cr | 27.7% |
| Quant Gilt Fund Direct Growth Moderate Risk | 0.5% | 0.0% | ₹130.22 Cr | 8.7% |
| Quant Manufacturing Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹1042.52 Cr | 39.5% |
| Quant Business Cycle Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹1546.30 Cr | 32.7% |
| Quant ESG Equity Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹309.31 Cr | 32.5% |
| Quant Overnight Fund Direct Growth Low Risk | 0.1% | 0.0% | ₹195.99 Cr | 7.0% |
| Quant Large Cap Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹2499.65 Cr | 32.1% |
| Quant Dynamic Asset Allocation Fund Direct Growth High Risk | 0.7% | 1.0% | ₹1349.99 Cr | 33.2% |
Risk Level
Your principal amount will be at Very High Risk
Unlock Expert Insights!
Related Articles
Still got questions?
We're here to help.
What is the current NAV of quant Healthcare Fund Direct Growth?
What is the portfolio composition of quant Healthcare Fund Direct Growth?
Who manages the quant Healthcare Fund Direct Growth?
- Sanjeev Sharma
- Vasav Sahgal
- Ankit A. Pande
- Sandeep Tandon
Trending Mutual Funds Searches
Popular Equity Funds
Popular Debt Funds
Dezerv Investments Private Limited is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.
Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.